Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Keele University Awarded Funds to Research Chemotherapy Resistance in Ovarian Cancer

17.11.2006
New research into the treatment of ovarian cancer, which could result in better treatment and survival rates for sufferers, is the latest research project to be awarded a grant by WellBeing of Women, the only UK charity dedicated to solving the health problems that solely affect women.

WellBeing of Women has awarded Miss Esther Moss at Keele University a Research Training Fellowship of over £101,500 to identify the specific genes involved in chemotherapy resistance in ovarian cancer. Funds for the research were raised by the generous support of the general public during the charity’s annual ovarian cancer awareness campaign, which has run for the past four years.

Ovarian cancer is currently diagnosed in almost 7,000 women in the UK each year. Despite advances in surgical techniques and chemotherapy treatments, very few women with ovarian cancer will survive long-term - the 5-year survival rate is around 30% (compared with 70% for breast cancer). Chemotherapy is an effective initial treatment for late stage ovarian cancer with approximately 70-80% of patients experiencing a reduction in the size of the cancer (partial response), or the disappearance of the cancer (complete response).

Carboplatin used in chemotherapy for ovarian cancer, kills tumour cells by forcing them to undergo programmed cell death (apoptosis). However these effects are not sustained and the majority of tumours will recur due to the growth of drug resistant cancer cells, which escape apoptosis. Previous research has shown that there are differences in gene expression, between cancer cells killed by the chemotherapy, and those that are able to survive.

Commenting of the study, Miss Esther Moss said, ”The primary outcome of this research will be to identify genes whose function, when disrupted, leads to chemo resistance in ovarian cancer. Identification of the genes involved in resistance to chemotherapy might provide biomarkers to aid in the conventional management of patients, and may also lead to the development of novel mechanism-based therapies for ovarian cancer.”

The charity’s Director, Liz Campbell said; “These awards are particularly important in encouraging medical graduates to pursue obstetrics and gynaecology at a time when different specialties are competing for the brightest and best. Research Training Fellowships are just one way that WellBeing of Women makes a valuable contribution to the development of tomorrow’s innovative medical leaders.”

Chris Stone | alfa
Further information:
http://www.keele.ac.uk

More articles from Health and Medicine:

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Stiffness matters

22.02.2018 | Life Sciences

Magnetic field traces gas and dust swirling around supermassive black hole

22.02.2018 | Physics and Astronomy

First evidence of surprising ocean warming around Galápagos corals

22.02.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>